文献速递乳腺乳腺X线MR

高危乳腺癌女性筛查中CEDM与MRI的比较:一项先导研究

Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study.
PubMed 文献 · Eur J Radiol · 2017-10-07

这项先导研究在2012年12月至2015年5月纳入318例乳腺癌高危女性,在计划MRI之外加做筛查性CEDM,CEDM对MRI设盲,以病理联合2年影像随访为参考标准。首轮筛查检出3例癌症,MRI全部检出,CEDM检出2例浸润性癌,3例均未在低能图(相当于常规乳腺X线)上显示。CEDM的PPV3为15%(2/13,95%CI:2-45%),MRI为14%(3/21,95%CI:3-36%);特异度分别为94.7%和94.1%。作者认为CEDM可能作为高危女性补充影像检查有价值,但需在更大规模多机构试验中验证。

要点

  • 首轮筛查3例癌症均未被低能图(相当于常规乳腺X线)显示,MRI全部检出,CEDM检出2例浸润性癌。
  • CEDM的PPV3为15%(2/13,95%CI:2-45%),MRI为14%(3/21,95%CI:3-36%)。
  • CEDM特异度94.7%,MRI特异度94.1%。

核心结论

  • CEDM和MRI均能检出常规乳腺X线未显示的额外癌症,主要为浸润性癌;先导数据提示CEDM可能作为不符合MRI标准或MRI可及性有限的高危女性的补充影像检查,但需在更大规模多机构试验中验证。

研究设计与样本

  • IRB批准、符合HIPAA的前瞻性先导研究,2012年12月至2015年5月纳入318例乳腺癌高危女性,在计划筛查MRI之外加做CEDM,CEDM在30天内完成并对MRI设盲解读,参考标准为病理联合2年影像随访,307/318例可评估。

关键影像表现/征象

  • 首轮筛查检出3例癌症(2例浸润性癌、1例导管原位癌),MRI全部检出,CEDM检出2例浸润性癌。
  • 3例癌症均未在低能乳腺X线图(与常规乳腺X线相当)上显示。
  • 2年影像随访期间额外检出5例筛查发现的癌症,无触及性癌症。

诊断标准与关键数值

  • CEDM的PPV3为15%(2/13,95%CI:2-45%),MRI的PPV3为14%(3/21,95%CI:3-36%)。
  • CEDM特异度94.7%,MRI特异度94.1%。

临床应用与阅片要点

  • 作者认为CEDM可能作为不符合MRI标准或MRI可及性有限的高危女性的补充影像检查有价值。
  • 作者指出需在更大规模多机构试验中验证。

局限性

  • 作者指出需在更大规模多机构试验中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Contrast enhanced digital mammography (CEDM) is a new breast imaging technology increasingly used in the diagnostic setting but its utility in the pure screening setting has not been reported. The goal of this pilot study is to prospectively compare screening CEDM to breast MRI in women with an increased risk for breast cancer.

METHODS: In this IRB-approved HIPAA-compliant study, 318 women at increased breast cancer risk were consented (December 2012-May 2015) to undergo CEDM in addition to their scheduled MRI. CEDM was performed within 30days of screening MRI. CEDM was interpreted blinded to MRI. The reference standard was defined as a combination of pathology and 2-year imaging follow-up.

RESULTS: Data from 307/318 patients were evaluable. Three cancers (two invasive cancers, one ductal carcinoma in situ) were detected at first round screening: MRI detected all three and CEDM detected the two invasive cancers. None of the three cancers was seen on the low energy mammograms which are comparable to conventional mammography. At 2year imaging follow up, there were 5 additional screen detected cancers and no palpable cancers. The positive predictive value 3 (PPV3) for CEDM was 15% (2/13, 95% CI: 2-45%) and 14% for MRI (3/21, 95% CI: 3-36%). The specificity of CEDM and MRI were 94.7% and 94.1% respectively.

CONCLUSIONS: Both CEDM and MRI detected additional cancers not seen on conventional mammography, primarily invasive cancers. Our pilot data suggest that CEDM could be valuable as a supplemental imaging exam for women at increased risk for breast cancer who do not meet the criteria for MRI or for whom access to MRI is limited. Validation in larger multi institutional trials is warranted.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Jochelson MS, Pinker K, Dershaw DD, et al. Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study. Eur J Radiol. 2017. PMID: 29153365. doi:10.1016/j.ejrad.2017.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。